Setipiprant
Setipiprant (INN; developmental code names ACT-129968, KYTH-105) is an investigational drug developed for the treatment of asthma and scalp hair loss. It was originally developed by Actelion and acts as a selective, orally available antagonist of the prostaglandin D2 receptor 2 (DP2). The drug is being developed as a novel treatment for male pattern baldness by Allergan.
Read “Setipiprant” on Wikipedia and its adverse effects · text from Wikipedia, CC BY-SA 4.0
Information, not medical advice. Talk to a licensed doctor or pharmacist before starting or changing a treatment.
Research 1
All on OpenAlex →Posts 20
- What's going on with hmi115? The Phase 2 was concluded Nov2024 but no news
- Setipiprant Side Effects
- If PP405 doesn't work then why would Pelage continue with trials?
- Setipiprant Does Work, But Only On Really Really High Doses.
- How the hell is this site able to Sell Setipiprant publicly?
- Setipiprant trial results
- Where can i buy Setipiprant from ? Does it work ? and are there any threads anyone could link so i could check it out and also suppliers? thanks
- The New, Improved CB-03-01/Setipiprant Group Buy
- Warning about Kanes Setipiprant
- Why not to use the substances like Setipiprant and Ru58441
- setipiprant
- SETIPIPRANT PGE2 GROUP BUY AND PIONEERING HAIR GROWTH
- PSA: If you bought Setipiprant from Kane make sure to get it tested
- Will Setipiprant ever get cheaper?
- Cheap Setipiprant. testing being done as we speak
- Is the Hair loss community still hopeful that Setipiprant will turn out to be a game changer?
- Setipiprant users
- Clinical Trial results: 12 months of taking VDPHL01, by Veradermics
- Prostaglandin Update (Maintaining and a little bit of Regrowth | Waiting for Fevipiprant)
- Anyone who is using Setipiprant?